Loading clinical trials...

A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension | Clinical Trials | Clareo Health

COMPLETEDPHASE2

A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension

NCT01863953•Allergan

View on ClinicalTrials.gov

Summary

This is a safety and efficacy study of fixed-combination bimatoprost and brimonidine compared with LUMIGAN® and ALPHAGAN® in patients with chronic glaucoma or ocular hypertension.

Eligibility

Age

40 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Diagnosis of ocular hypertension or glaucoma
•Requires intraocular pressure (IOP)-lowering therapy

Exclusion Criteria

•Cataract surgery in one eye
•Ocular laser or intraocular surgery within 6 months
•Refractive surgery in either eye
•Anticipated use of contact lenses during the study
•Expected use of artificial tears during the study

Locations (1)

Newport Beach, California, United States

Key Dates

Start Date

June 1, 2013

Primary Completion Date

December 1, 2013

Completion Date

December 1, 2013

Last Updated

January 26, 2015

Enrollment

112

ACTUAL participants

Conditions

GlaucomaOcular Hypertension

Interventions

Fixed-Combination Bimatoprost/Brimonidine

DRUG

Bimatoprost Ophthalmic Solution 0.01%

DRUG

Vehicle Ophthalmic Solution

DRUG

Brimonidine Tartrate Ophthalmic Solution 0.2%

DRUG

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

NCT04354545

GlaucomaOcular Surface Disease

View study

RECRUITINGNA

Automated Applanation Tonometry - Updated

NCT07298356

GlaucomaGlaucoma, Suspect

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 26, 2015Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension

Inclusion Criteria

Exclusion Criteria

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

Automated Applanation Tonometry - Updated

Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye

Efficacy and Safety of Tran Cannula in Combined Pseudoexfoliative Glaucoma and Cataract Surgery Compared With Augmented Ocular Irrigation

DSLT for Reducing Medication in Glaucoma

Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies